Estradiol cypionate/testosterone enanthate
Not to be confused with Estradiol cypionate/testosterone cypionate or Supligol NF.
Combination of | |
---|---|
Estradiol cypionate | Estrogen |
Testosterone enanthate | Androgen; Anabolic steroid |
Clinical data | |
Trade names | Supligol |
Other names | EC/TE |
Routes of administration | Intramuscular injection |
Identifiers | |
CAS Number |
Estradiol cypionate/testosterone enanthate (EC/TE), sold under the brand name Supligol, is an injectable combination medication of estradiol cypionate (EC), an estrogen, and testosterone enanthate (TE), an androgen/anabolic steroid, which is used in menopausal hormone therapy for women, to treat prostatic hypertrophy in men, to treat osteoporosis, and to suppress lactation in women, among other uses.[1][2] It contains 4 mg EC and 80 mg TE (57.5 mg free testosterone) in oil solution in each ampoule and is administered by intramuscular injection once every 3 to 6 weeks for hormone therapy in women.[1] The medication was marketed by 1976[1] and remains available today in Paraguay.[2]
Route | Medication | Major brand names | Form | Dosage |
---|---|---|---|---|
Oral | Testosterone undecanoate | Andriol, Jatenzo | Capsule | 40–80 mg 1x/1–2 days |
Methyltestosterone | Metandren, Estratest | Tablet | 0.5–10 mg/day | |
Fluoxymesterone | Halotestin | Tablet | 1–2.5 mg 1x/1–2 days | |
Normethandronea | Ginecoside | Tablet | 5 mg/day | |
Tibolone | Livial | Tablet | 1.25–2.5 mg/day | |
Prasterone (DHEA)b | – | Tablet | 10–100 mg/day | |
Sublingual | Methyltestosterone | Metandren | Tablet | 0.25 mg/day |
Transdermal | Testosterone | Intrinsa | Patch | 150–300 μg/day |
AndroGel | Gel, cream | 1–10 mg/day | ||
Vaginal | Prasterone (DHEA) | Intrarosa | Insert | 6.5 mg/day |
Injection | Testosterone propionatea | Testoviron | Oil solution | 25 mg 1x/1–2 weeks |
Testosterone enanthate | Delatestryl, Primodian Depot | Oil solution | 25–100 mg 1x/4–6 weeks | |
Testosterone cypionate | Depo-Testosterone, Depo-Testadiol | Oil solution | 25–100 mg 1x/4–6 weeks | |
Testosterone isobutyratea | Femandren M, Folivirin | Aqueous suspension | 25–50 mg 1x/4–6 weeks | |
Mixed testosterone esters | Climacterona | Oil solution | 150 mg 1x/4–8 weeks | |
Omnadren, Sustanon | Oil solution | 50–100 mg 1x/4–6 weeks | ||
Nandrolone decanoate | Deca-Durabolin | Oil solution | 25–50 mg 1x/6–12 weeks | |
Prasterone enanthatea | Gynodian Depot | Oil solution | 200 mg 1x/4–6 weeks | |
Implant | Testosterone | Testopel | Pellet | 50–100 mg 1x/3–6 months |
Notes: Premenopausal women produce about 230 ± 70 μg testosterone per day (6.4 ± 2.0 mg testosterone per 4 weeks), with a range of 130 to 330 μg per day (3.6–9.2 mg per 4 weeks). Footnotes: a = Mostly discontinued or unavailable. b = Over-the-counter. Sources: See template. |
See also
References
- 1 2 3 Vademecum de bolsillo: guía de especialidades medicinales : con índice terapéutico actualizado (enfermedades y síntomas de urgencia). Editorial Celcius - J.J. Vallory. 1976.
SUPLIGOL (Ampollas) Comp. Testosterona enantato 80 mg (-= Testosterona 57,5 mg) y Estradiol ciclopentil-propionato, 4 mg. — Indic. Climaterio y sus trastornos, hipertrofia de la próstata, osteoporosis, supresión de la lactancia, etc. — Doslf. Climaterio: 1 ampolla por via I.M. cada 3-6 semanas, segun el caso. Osteoporosis: 1 ampolla cada 3 semanas. Supresion de la lactancia: 1 ampolla despues del parto.
- 1 2 https://www.drugs.com/international/supligol.html
Androgens (incl. AAS) |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antiandrogens |
| ||||||||||||
|
Estrogen receptor modulators | |||||||
---|---|---|---|---|---|---|---|
ER |
| ||||||
GPER |
| ||||||
|
Androgen receptor modulators | |||||||
---|---|---|---|---|---|---|---|
AR |
| ||||||
GPRC6A |
| ||||||
|
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.